The Cigna Group
CI
$298.49
$9.423.26%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 68.29B | 72.13B | 69.52B | 66.94B | 65.26B |
| Total Other Revenue | 202.00M | 339.00M | 233.00M | 236.00M | 238.00M |
| Total Revenue | 68.49B | 72.47B | 69.75B | 67.18B | 65.50B |
| Cost of Revenue | 62.02B | 66.06B | 63.37B | 61.02B | 58.90B |
| Gross Profit | 6.47B | 6.42B | 6.38B | 6.16B | 6.61B |
| SG&A Expenses | 2.33B | 3.40B | 3.15B | 3.27B | 3.80B |
| Depreciation & Amortization | 390.00M | 463.00M | 436.00M | 422.00M | 422.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 64.74B | 69.91B | 66.96B | 64.71B | 63.12B |
| Operating Income | 3.75B | 2.56B | 2.79B | 2.47B | 2.39B |
| Income Before Tax | 2.27B | 1.82B | 2.30B | 2.02B | 1.65B |
| Income Tax Expenses | 409.00M | 543.00M | 322.00M | 389.00M | 239.00M |
| Earnings from Continuing Operations | 1.86B | 1.27B | 1.97B | 1.63B | 1.41B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -207.00M | -40.00M | -105.00M | -100.00M | -86.00M |
| Net Income | 1.65B | 1.23B | 1.87B | 1.53B | 1.32B |
| EBIT | 3.75B | 2.56B | 2.79B | 2.47B | 2.39B |
| EBITDA | 4.40B | 3.28B | 3.49B | 3.15B | 3.06B |
| EPS Basic | 6.30 | 4.67 | 7.02 | 5.76 | 4.88 |
| Normalized Basic EPS | 7.29 | 5.05 | 5.35 | 4.63 | 4.35 |
| EPS Diluted | 6.26 | 4.65 | 6.98 | 5.71 | 4.85 |
| Normalized Diluted EPS | 7.25 | 5.02 | 5.31 | 4.59 | 4.32 |
| Average Basic Shares Outstanding | 262.75M | 264.07M | 265.91M | 266.18M | 270.87M |
| Average Diluted Shares Outstanding | 264.02M | 265.67M | 267.53M | 268.15M | 272.95M |
| Dividend Per Share | 1.56 | 1.51 | 1.51 | 1.51 | 1.51 |
| Payout Ratio | 25.21% | 32.09% | 21.52% | 26.17% | 31.14% |